Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 824.66M P/E - EPS this Y - Ern Qtrly Grth -
Income -10.55M Forward P/E - EPS next Y - 50D Avg Chg 5.00%
Sales 245.32M PEG - EPS past 5Y - 200D Avg Chg 5.00%
Dividend N/A Price/Book 4.03 EPS next 5Y - 52W High Chg -30.00%
Recommedations - Quick Ratio 3.28 Shares Outstanding 67.34M 52W Low Chg 45.00%
Insider Own - ROA -3.06% Shares Float 657.77M Beta 0.74
Inst Own 0.07% ROE -4.98% Shares Shorted/Prior 1.32K/2.72K Price 12.50
Gross Margin 89.72% Profit Margin -4.30% Avg. Volume 2,732 Target Price -
Oper. Margin -18.83% Earnings Date May 8 Volume 6 Change -1.96%
About Pharming Group N.V.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Pharming Group N.V. News
04/24/24 Pharming Group to report first quarter 2024 financial results on May 8
04/24/24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
04/22/24 Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
04/19/24 Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
04/18/24 Pharming Group announces the placement of €100 million convertible bonds due 2029
04/18/24 Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
04/08/24 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
04/04/24 Pharming Group announces the 2024 Annual General Meeting of Shareholders
04/04/24 Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
04/03/24 Pharming Group to participate in April investor conferences
03/17/24 Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
03/16/24 Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)
03/14/24 Pharming Group reports fourth quarter and full year 2023 financial results
02/29/24 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
02/08/24 Pharming Group to participate in February investor conferences
01/08/24 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
12/13/23 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
11/21/23 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
11/10/23 Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval
11/07/23 Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting
PHAR Chatroom

User Image Burnshortssince1988 Posted - 04/30/24

$MULN $PHAR next to double

User Image AriVe Posted - 04/26/24

$PHAR Voor nieuwe mensen hier, als je een account aanmaakt pas dan op dat je je eigen naam niet in je account zet. Deze is dan zichtbaar voor iedereen.

User Image AriVe Posted - 04/26/24

$PHAR

User Image DrMonitor Posted - 04/24/24

$PHAR @Dieptebom zit je ook op IEX Robert Mureau?

User Image JelleM8 Posted - 04/18/24

$PHAR Zo slecht was het nieuws nou toch ook niet? Beetje overspannen reactie vandaag.

User Image Noobnr1 Posted - 04/18/24

$PHAR So this is the moment for shopping 🫨 announced and so dark red 🤢 unbelieveable 🙄 Please 2 medicins on the market deserve better stock value Also $PFE and $GILD wat to low 💎

User Image AriVe Posted - 04/11/24

$PHAR mooi volume voor vs begrippen

User Image AriVe Posted - 04/09/24

$PHAR Van mij mogen ze een overname of andere deal doen hoor. Genoeg veelbelovende bedrijven die nog een lage markt waarde hebben, misschien zelfs wel dankzij de marktmakers wie dat dan ook mogen zijn. Iemand een idee welke hoek we een beetje moeten zoeken?

User Image AriVe Posted - 04/09/24

$PHAR Hoe zal de exit van SDV nu uiteindelijk gaan verlopen. Zal hij dan zijn aandelen allemaal verkopen of niet, hij zal er nu hij er zelf nog de scepter zwaait toch nog wel een konijn uit de hoed willen toveren en een mooi afscheid hebben.

User Image AriVe Posted - 04/09/24

$PHAR Zelf grotendeels uit pharming heb er nog een paar duizend, grote fouten gemaakt met blue, mooie kans gehad om er toch nog met een mooie winst uit te komen. Mijn idee was nog steeds dat blue meer waard was dus blijven zitten. nu nog 15 cent p.a onder water SLS is een andere grote positie, daar gaat ie wel erg lekker. Maar jah Pharming gerelateerd.

User Image AriVe Posted - 04/09/24

$PHAR Pharming UPP!!

User Image AriVe Posted - 04/09/24

$PHAR 10 dollar, we een mooi rond getal. Ga even wat plaatjes zetten om de postst van hieronder wat weg te werken. Privacy is een groot goed nietwaar.

User Image DrMonitor Posted - 04/07/24

$PHAR zit je ook op dit forum klikbilt?

User Image DrMonitor Posted - 03/24/24

$PHAR @Dieptebom zit je ook op IEX Robert Mureau?

User Image Haardvuurtje Posted - 03/18/24

$BLUE patience required, but hopefully not as long as $PHAR

User Image DrMonitor Posted - 03/18/24

$PHAR Pharming lied to their investors again! Pharming did sent a request for adoption of a longer clock stop to answer the questions which they new two days BEFORE the yearly figures but lied to their investors! Sijmen is unreliable and also uncapable.

User Image Thestocktraderhubzee Posted - 03/14/24

$PHAR HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

User Image newinvestor5555 Posted - 03/14/24

$PHAR I seriously do not understand this stock . Why it goes the other direction?

User Image newinvestor5555 Posted - 03/14/24

$PHAR everything looks great. Why doesn’t it move ?

User Image Burnshortssince1988 Posted - 03/06/24

$MULN moon + pharming $PHAR

User Image DrMonitor Posted - 03/05/24

$PHAR Pharming pre-market: -5,6% In Europe Pharming entering the state of penny-stock again. Next week: yearly report. Profit? Loss again? Any news from the European Medicine Agency? Or will Pharming hide this again?

User Image DrMonitor Posted - 02/28/24

$PHAR 4 years ago Pharming noted 1.12 Today Pharming's share price: 1.05 What is your result in this stock clown Ruudje Hellewegen? @Declan1NL na al je domme beweringen?

User Image Ziebof Posted - 02/20/24

$PHAR When european approval for Leniosilib will come by EMA this quarter this will boom!

User Image DrMonitor Posted - 02/17/24

$PHAR Pharming nearing €1 stock price in Europe. RTW investments leaving Pharming..

User Image JelleM8 Posted - 02/13/24

$PHAR mooie dag weer 🙄

User Image DrMonitor Posted - 3 months ago

$PHAR Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine https://finance.yahoo.com/news/intellia-therapeutics-announces-publication-positive-220000512.html

User Image EarningsInsider Posted - 01/26/24

Pharming Group Sees Short Interest Decrease from 1,000 shares to 700 shares. $PHAR https://www.marketbeat.com/stocks/NASDAQ/PHAR/short-inte

User Image Noobnr1 Posted - 01/25/24

$ONCO 😁🚀🚀 200% +++ $ARDX $OMER $GILD $PHAR

User Image DrMonitor Posted - 01/22/24

$PHAR RTW investments leaving Pharming They significantly lowered their interest in Pharming! Just before the EMA review of leniolisib. Bad news comming?

User Image ericaarts Posted - 01/21/24

$PHAR from Simlpy Wallst

Analyst Ratings
HC Wainwright & Co. Buy Mar 14, 24
HC Wainwright & Co. Buy Aug 3, 23
Oppenheimer Outperform Mar 28, 23
HC Wainwright & Co. Buy Mar 27, 23
HC Wainwright & Co. Buy Feb 22, 23
HC Wainwright & Co. Buy Feb 16, 23